Targeting NF-κB-inducing kinase (NIK) in immunity, inflammation, and cancer

KM Pflug, R Sitcheran - International journal of molecular sciences, 2020 - mdpi.com
NF-κB-inducing kinase (NIK), the essential upstream kinase, which regulates activation of
the noncanonical NF-κB pathway, has important roles in regulating immunity and …

[HTML][HTML] Role and mechanisms of the NF-ĸB signaling pathway in various developmental processes

P Liu, Y Li, W Wang, Y Bai, H Jia, Z Yuan… - Biomedicine & …, 2022 - Elsevier
Since the discovery of the nuclear factor kappa B (NF-ĸB) transcription factor 36 years ago,
many studies have linked the NF-ĸB signaling pathway to pathological and physiological …

4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling

BI Philipson, RS O'Connor, MJ May, CH June… - Science …, 2020 - science.org
Clinical response to chimeric antigen receptor (CAR) T cell therapy is correlated with CAR T
cell persistence, especially for CAR T cells that target CD19+ hematologic malignancies. 4 …

[HTML][HTML] Calcium phosphate-based materials regulate osteoclast-mediated osseointegration

X Wang, Y Yu, L Ji, Z Geng, J Wang, C Liu - Bioactive Materials, 2021 - Elsevier
Calcium phosphate-based materials (CaP) have been widely used as bone graft substitutes
with a decent osseointegration. However, the mechanism whereby cells function and repair …

NF-κB in biology and targeted therapy: new insights and translational implications

Q Guo, Y Jin, X Chen, X Ye, X Shen, M Lin… - … and Targeted Therapy, 2024 - nature.com
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was
identified as a pivotal pathway in mediating inflammatory responses. However, with …

Myeloid-derived growth factor alleviates non-alcoholic fatty liver disease alleviates in a manner involving IKKβ/NF-κB signaling

Y Ding, X Xu, B Meng, L Wang, B Zhu, B Guo… - Cell Death & …, 2023 - nature.com
Whether bone marrow modulates systemic metabolism remains unknown. Our recent study
suggested that myeloid-derived growth factor (MYDGF) improves insulin resistance. Here …

Recent developments and challenges in molecular-targeted therapy of non-small-cell lung cancer

S Rohilla, M Singh, SI Alzarea… - Journal of …, 2023 - dl.begellhouse.com
Treatment of lung cancer with conventional therapies, which include radiation, surgery, and
chemotherapy results in multiple undesirable adverse or side effects. The major clinical …

[HTML][HTML] A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells

JZ Shen, Z Qiu, Q Wu, G Zhang, R Harris, D Sun… - Molecular cell, 2022 - cell.com
A mesenchymal tumor phenotype associates with immunotherapy resistance, although the
mechanism is unclear. Here, we identified FBXO7 as a maintenance regulator of …

[HTML][HTML] Canagliflozin ameliorates nonalcoholic fatty liver disease by regulating lipid metabolism and inhibiting inflammation through induction of autophagy

Z Xu, W Hu, B Wang, T Xu, J Wang… - Yonsei Medical Journal, 2022 - ncbi.nlm.nih.gov
Purpose Nonalcoholic fatty liver disease (NAFLD) is closely associated with metabolic
diseases, including obesity and diabetes, and has gradually become the most common …

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

Y Zhang, S Zhu, Y Du, F Xu, W Sun, Z Xu… - Journal of Experimental …, 2022 - Springer
Background The interaction between programmed death receptor (PD-1) and its ligand (PD-
L1) is essential for suppressing activated T-lymphocytes. However, the precise mechanisms …